04/23/2024
4:00 PM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
3:48 PM | Renalytix (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/09/2024
3:51 PM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:31 PM | Renalytix (Filer)
| Form 424B5 | |
04/08/2024
6:44 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
9:15 AM | CVI Investments, Inc. (Filed by)
Renalytix (Subject)
| Form SC 13G | |
03/29/2024
4:05 PM | Renalytix (Filer)
| Form DEF 14A | |
|
03/21/2024
2:30 PM | JEFFERSON RIVER CAPITAL LLC (Filed by)
Renalytix (Subject)
| Form SC 13D/A | |
03/14/2024
6:15 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
5:37 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
5:05 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
6:15 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
6:15 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:02 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
4:00 PM | Renalytix (Filer)
| Form DEFA14A | |
11/22/2023
3:27 PM | Doran Howard JR (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:27 PM | MILLS CHRISTOPHER (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:28 PM | Parikh Chirag R. (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:28 PM | LEVANGIE DANIEL J (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:29 PM | Coste Catherine (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:15 PM | Renalytix (Filer)
| Form DEFR14A | |
11/13/2023
8:22 AM | Renalytix (Filer)
| Form DEF 14A | |
10/24/2023
7:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
7:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2023
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
10/09/2023
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
10/09/2023
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
10/05/2023
7:30 PM | Renalytix (Filer)
| Form 10-K/A | |
10/03/2023
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
8:42 PM | Renalytix (Filer)
| Form RW WD | |
10/02/2023
3:00 PM | Renalytix (Filer)
| Form RW | |
09/28/2023
6:31 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
5:49 AM | Renalytix (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/28/2023
5:54 AM | Renalytix (Filer)
| Form POS AM | |
09/28/2023
5:55 AM | Renalytix (Filer)
| Form POS AM | |
09/28/2023
5:58 AM | Renalytix (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/28/2023
5:18 AM | Renalytix (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/22/2023
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you?
In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants.
Absolutely no strings attached. Secure Your Spot Now |
09/12/2023
3:15 PM | Doran Howard JR (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
4:16 PM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
3:49 PM | MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:24 PM | Renalytix (Issuer)
Sterling O. James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:25 PM | Fleming Fergus (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:26 PM | MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:27 PM | McCullough James Renwick (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:28 PM | Coste Catherine (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:29 PM | Donovan Michael J. (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:20 PM | LEVANGIE DANIEL J (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:21 PM | Lium Erik (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:21 PM | McCullough James Renwick (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:22 PM | MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:23 PM | MILLS CHRISTOPHER (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:23 PM | Parikh Chirag R. (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:24 PM | Renalytix (Issuer)
Scannell Timothy J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:24 PM | Renalytix (Issuer)
Sterling O. James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:19 PM | Coste Catherine (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:19 PM | Donovan Michael J. (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:20 PM | Fleming Fergus (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
1:30 PM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
7:55 AM | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
MOUNT SINAI HEALTH SYSTEM, INC. (Reporting)
MOUNT SINAI HOSPITAL (Reporting)
MOUNT SINAI HOSPITALS GROUP, INC. (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
7:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
6:00 AM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2023
6:01 AM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2023
6:00 AM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/11/2023
4:02 PM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/11/2023
8:30 AM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2023
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
05/02/2023
3:40 PM | Renalytix (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
